Kexing Biopharm Logo

Kexing Biopharm

Develops and produces recombinant protein drugs and micro-ecological preparations.

688136 | Shanghai Stock Exchange

Overview

Corporate Details

ISIN(s):
CNE100006ZG6
LEI:
529900Z34Q1M9A907771
Country:
China
Address:
N/A

Description

Kexing Biopharm is an innovative biopharmaceutical enterprise engaged in the research, development, production, and sales of recombinant protein drugs and micro-ecological preparations. The company focuses on developing treatments for therapeutic areas including kidney diseases, oncology, antiviral therapy, autoimmune disorders, metabolic diseases, and degenerative diseases. A key product in its portfolio is Erythropoietin Injection. Kexing Biopharm maintains a comprehensive quality system that aligns with international standards, covering the entire drug lifecycle from production and quality control to release and transportation, ensuring the continuous and stable manufacturing of safe and effective medicines.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-01 21:05
Kexing Biopharm prasentiert globale Strategie und Kooperationsmoglichkeiten auf…
German 6.4 KB

Automate Your Workflow. Get a real-time feed of all Kexing Biopharm filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kexing Biopharm

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kexing Biopharm via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Formycon AG Logo
A biopharmaceutical company developing high-quality biosimilars for complex medicines.
Germany
FYB
Forte Biosciences, Inc. Logo
A clinical-stage biopharma firm developing treatments for autoimmune-related diseases.
United States of America
FBRX
Fortress Biotech, Inc. Logo
Biopharmaceutical firm that develops and commercializes a diversified drug portfolio.
United States of America
FBIO
FRACTYL HEALTH, INC. Logo
Develops therapies targeting the root causes of obesity and type 2 diabetes.
United States of America
GUTS
Friulchem Logo
A contract development and manufacturing organization for the animal health sector.
Italy
FCM
Fuji Pharma Co.,Ltd. Logo
Pharmaceutical firm focused on women's healthcare and contract manufacturing services.
Japan
4554
Fulcrum Therapeutics, Inc. Logo
Develops small molecule therapies for rare, genetically defined diseases.
United States of America
FULC
FunPep Company Limited Logo
Develops therapeutic solutions derived from functional peptides.
Japan
4881
Fuso Pharmaceutical Industries,Ltd. Logo
Develops and manufactures pharmaceuticals, focusing on infusions and dialysis solutions.
Japan
4538
FUTURA MEDICAL PLC Logo
Pharmaceutical company developing topical gel formulations for sexual health.
United Kingdom
FUM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.